Senate Finance Committee leaders are in talks to create legislation that would require drug companies to pay rebates to Medicare Part D if drug prices grow faster than inflation, according to The Hill.
A rebate program is considered "far-reaching," and may face opposition from Republicans as it nears price control, The Hill reports. However, leaders involved in talks include Finance Committee Chairman Chuck Grassley, R-Iowa, and Sen. Ron Wyden, D-Ore., indicating potential bipartisan support.
The proposal is separate from surprise medical billing legislation being developed by the health committee, but The Hill reports the two proposals could be combined into one package before coming to a vote.
Read more here.
More articles on leadership and management:
Ochsner CEO Warner Thomas on healthcare in the 2020 election, price transparency & innovation
5 healthcare takeaways from the 1st Democratic debate
Hospital alarms and the 'devil's interval': Why one musician wants to change the hospital soundscape